The sector specialists
Middle market deals have been a sweet spot in for PE firms in Asia, but competition in is also intense in the U.S. Sector-specific knowledge could be the key to success, as AVCJ finds out from Tony de Nicola, Co-President of Welsh, Carson, Anderson & Stowe.
Q: WCAS is a well known firm in the U.S. but many Asian readers may be unfamiliar with it. Can you talk a bit about the firm and your strategy? A: Welsh, Carson, Anderson & Stowe is a private equity...
More on GPs
Latest News
Hong Kong's Animoca raises $359m at $5b valuation
US-based Liberty City Ventures has led a USD 359m round for Hong Kong blockchain media company Animoca Brands at a pre-money valuation of USD 5bn, more than double its valuation in October.
China beauty retailer Harmay raises $200m
Harmay, a China-based omnichannel beauty products retailer, has raised USD 200m across Series C and D rounds.
TPG-owned clinical trials player raises new equity, debt
Novotech, an Asia-based clinical trials specialist controlled by TPG Capital, has secured USD 760m in new equity and debt financing at a post-deal valuation of approximately USD 3bn.
Quadrant exits Australia experiential tourism business
Quadrant Private Equity has sold Journey Beyond, an Australia-based experiential tourism business, to US-based Hornblower Group, which is best known for offering cruise and sightseeing packages.